LIANY OTC
LianMedical
1W: -2.9%
1M: +45.6%
3M: -47.3%
YTD: -38.7%
1Y: +7.9%
3Y: +698.5%
$0.06
+0.01 (+14.22%)
Weekly Expected Move ±30.6%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$801K
+39.6% ▲
Operating Income
-$39M
+61.0% ▲
Net Income
$2M
-99.2% ▼
EPS (Diluted)
$0.02
-99.2% ▼
EBITDA
$3M
-99.0% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $76K | $526K | $1M | $1M | $801K |
| Gross Profit | -$76K | -$526K | -$1M | -$1M | -$801K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $121M | $159M | $60M | $35M | $11M |
| SG&A Expenses | $14M | $37M | $65M | $63M | $27M |
| Operating Expenses | $135M | $195M | $124M | $98M | $38M |
| Operating Income | -$135M | -$196M | -$125M | -$100M | -$39M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$140M | -$196M | -$110M | $312M | $2M |
| Tax Expense | $4K | $519K | -$333K | $450K | -$22K |
| Net Income | -$140M | -$197M | -$110M | $311M | $2M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-1.33 | $-1.83 | $-1.02 | $2.87 | $0.02 |
| EBITDA | -$135M | -$196M | -$109M | $313M | $3M |
| Shares Outstanding | 105M | 107M | 108M | 108M | 109M |